Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

0.5549
Delayed Data
As of 3:59pm ET
 -0.0182 / -3.18%
Today’s Change
0.32
Today|||52-Week Range
6.90
-82.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues291.0K863.0K236.0K157.0K
 
 
 
 
 
Depreciation And Amortization29.0K12.0K13.0K67.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses13.5M52.2M17.7M15.1M
 
 
 
 
 
Research And Development9.2M44.8M13.4M8.7M
 
 
 
 
 
Total Operating Expenses13.5M52.2M17.7M15.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.2M-51.4M-17.5M-15.0M
 
 
 
 
 
Extraordinary Credit36.5M28.0M13.5M3.9M
 
 
 
 
 
Interest Expense On Debt1.0M678.0K718.0K729.0K
 
 
 
 
 
Other Expenses384.0K-52.0K-1.4M-2.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income22.6M-24.1M-6.1M-14.2M
 
 
 
 
 
Net Income22.6M-24.1M-6.1M-16.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS78.1M89.2M97.7M103.8M
 
 
 
 
 
Shares To Calculate EPS Diluted89.8M89.2M97.7M103.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.25-$0.27-$0.06-$0.16
 
 
 
 
 
EPS Diluted$0.25-$0.27-$0.06-$0.16